Lipodystrophy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BMY | B | Bristol-Myers Squibb Company | 1.10 | |
IONS | F | Ionis Pharmaceuticals, Inc. | 0.21 |
Related Industries: Biotechnology Drug Manufacturers - Major
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
FTXH | C | First Trust Nasdaq Pharmaceuticals ETF | 9.3 | |
MEDX | F | Horizon Kinetics Medical ETF | 9.01 | |
PPH | D | Market Vectors Pharmaceutical ETF | 5.89 | |
MVAL | A | SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF | 5.37 | |
RDIV | A | RevenueShares Ultra Dividend Fund | 5.27 |
Compare ETFs
- Lipodystrophy
Lipodystrophy syndromes are a group of genetic or acquired disorders in which the body is unable to produce and maintain healthy fat tissue. The medical condition is characterized by abnormal or degenerative conditions of the body's adipose tissue. ("Lipo" is Greek for "fat", and "dystrophy" is Greek for "abnormal or degenerative condition".) A more specific term, lipoatrophy, is used when describing the loss of fat from one area (usually the face). This condition is also characterized by a lack of circulating leptin which may lead to osteosclerosis. The absence of fat tissue is associated with insulin resistance, hypertriglyceridemia, non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles